Skip to main content
Clinical Trials/NCT05435391
NCT05435391
Unknown
Not Applicable

A Prospective, Multicenter, Observational Diagnostic Study to Externally Validate an Artificial Intelligence 12-lead Electrocardiogram Analysis Algorithm to Detect Patients With Acute Myocardial Infarction Who Visit Emergency Medical Center

CHA University1 site in 1 country8,814 target enrollmentMarch 16, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction or Chest Pain
Sponsor
CHA University
Enrollment
8814
Locations
1
Primary Endpoint
Diagnosis of acute myocardial infarction (Type 1, 2)
Last Updated
3 years ago

Overview

Brief Summary

This study is a prospective multicenter observational study for external validation and model advancement of a deep learning based 12-lead electrocardiogram analysis algorithm targeting adult patients presenting to the emergency department with chest pain and acute myocardial infarction equivalent symptoms.

About 9,000 adult patients will be enrolled at 20 emergency medical centers in Korea. Artificial intelligence algorithms are manufactured by Medical AI Co., Ltd. It is an advanced version based on the model developed and published in 2020. It had the diagnostic performance of area under the receiver operating curve 0.901 and 0.951 for acute myocardial infarction and ST-segment elevation myocardial infarction, respectively. The primary endpoint is a diagnosis of acute myocardial infarction on the day of the emergency center visit, and the secondary endpoint is a 30-day major adverse cardiac event. From March 2022, patient registration will begin at centers that have been approved by the Institutional Review Board.

This is the first prospective multicenter emergency department validation study for a 12-lead electrocardiogram artificial intelligence algorithm to diagnose acute myocardial infarction. This study will give insight into the direction of future development by verifying whether the deep learning algorithm works well for patients visiting the real-world adult emergency medical center.

Registry
clinicaltrials.gov
Start Date
March 16, 2022
End Date
May 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults over 18 years of age with suspected chest pain and acute myocardial infarction
  • The onset or worsening of the symptom occurs within 24 hours

Exclusion Criteria

  • Out-of-hospital cardiac arrest (OHCA): patients with sustained (\>20 minutes) return-of-spontaneous-circulation are not excluded
  • Patients in whom acute myocardial infarction can be clearly excluded, such as pneumothorax and traumatic chest pain

Outcomes

Primary Outcomes

Diagnosis of acute myocardial infarction (Type 1, 2)

Time Frame: Index admission

Accuracy metrics include area under the receiver operating characteristics curve, sensitivity, specificity, positive predictive value, and negative predictive value, along with a 95% confidence interval.

Secondary Outcomes

  • Major adverse cardiovascular event (MACE)(30-day after index admission)

Study Sites (1)

Loading locations...

Similar Trials